[go: up one dir, main page]

FI930799L - Piperazinylderivat - Google Patents

Piperazinylderivat Download PDF

Info

Publication number
FI930799L
FI930799L FI930799A FI930799A FI930799L FI 930799 L FI930799 L FI 930799L FI 930799 A FI930799 A FI 930799A FI 930799 A FI930799 A FI 930799A FI 930799 L FI930799 L FI 930799L
Authority
FI
Finland
Prior art keywords
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
FI930799A
Other languages
English (en)
Other versions
FI930799A0 (fi
FI930799A7 (fi
Inventor
Lone Jeppesen
Marit Kristiansen
John Bondo Hansen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of FI930799L publication Critical patent/FI930799L/fi
Publication of FI930799A0 publication Critical patent/FI930799A0/fi
Publication of FI930799A7 publication Critical patent/FI930799A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/101,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/141,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/161,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/18Ethylenedioxybenzenes, not substituted on the hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Quinoline Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI930799A 1990-08-24 1991-08-23 Piperatsinyylijohdannaisia FI930799A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK203990A DK203990D0 (da) 1990-08-24 1990-08-24 Piperazinylderivater
PCT/DK1991/000244 WO1992003426A1 (en) 1990-08-24 1991-08-23 Piperazinyl derivatives

Publications (3)

Publication Number Publication Date
FI930799L true FI930799L (fi) 1993-02-23
FI930799A0 FI930799A0 (fi) 1993-02-23
FI930799A7 FI930799A7 (fi) 1993-02-23

Family

ID=8109641

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930799A FI930799A7 (fi) 1990-08-24 1991-08-23 Piperatsinyylijohdannaisia

Country Status (16)

Country Link
US (1) US5246935A (fi)
EP (1) EP0544765B1 (fi)
JP (1) JPH06500546A (fi)
AT (1) ATE125802T1 (fi)
AU (1) AU653956B2 (fi)
CA (1) CA2089768A1 (fi)
DE (1) DE69111815T2 (fi)
DK (2) DK203990D0 (fi)
FI (1) FI930799A7 (fi)
IE (1) IE73475B1 (fi)
IL (1) IL99211A (fi)
NO (1) NO930631L (fi)
NZ (1) NZ239502A (fi)
PT (1) PT98768B (fi)
WO (1) WO1992003426A1 (fi)
ZA (1) ZA916652B (fi)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
US5436246A (en) * 1992-09-17 1995-07-25 Merrell Dow Pharmaceuticals Inc. Serotonin receptor agents
DK148392D0 (da) * 1992-12-09 1992-12-09 Lundbeck & Co As H Heterocykliske forbindelser
GB9300195D0 (en) * 1993-01-06 1993-03-03 Wyeth John & Brother Ltd Piperazine derivatives
US5453425A (en) * 1994-07-11 1995-09-26 Janssen Pharmaceutica N.V. Risperidone oral formulation
PL187926B1 (pl) * 1996-03-25 2004-11-30 Lilly Co Eli Kompozycja farmaceutyczna do leczenia bólu
CN1219878A (zh) * 1996-03-25 1999-06-16 伊莱利利公司 治疗疼痛的方法
EP0906104A4 (en) 1996-03-25 2003-12-10 Lilly Co Eli PAIN TREATMENT PROCESS
FR2753968B1 (fr) * 1996-09-27 1998-11-27 Sod Conseils Rech Applic Nouvelles heteroaryloxyethylamines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
US6344458B1 (en) 1998-12-17 2002-02-05 American Home Products Corporation Piperazine ethylamide derivatives
US6638970B2 (en) 2000-02-22 2003-10-28 Cv Therapeutics, Inc. Substituted alkylene diamine compounds
US20030186838A1 (en) * 2000-05-12 2003-10-02 Feenstra Roelof W. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
FR2821356A1 (fr) * 2001-02-23 2002-08-30 Cerep Nouveaux derives d'arylcarbamates et d'arylurees, preparations et utilisations
SE0103649D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic quinoline compounds
SE0103648D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic quinolone compounds
US6750367B2 (en) * 2002-05-09 2004-06-15 Bayer Polymers Llc Tetralin isocyanates
EP1553074B1 (en) 2002-08-12 2014-06-18 Takeda Pharmaceutical Company Limited Fused benzene derivative and use
JP2009527562A (ja) * 2006-02-21 2009-07-30 アムゲン インコーポレイティッド ホスホジエステラーゼ10阻害剤としてのシンノリン誘導体
PL2400968T3 (pl) * 2009-02-26 2017-04-28 Reviva Pharmaceuticals, Inc. Kompozycje, synteza i sposoby zastosowania pochodnych arylopiperazyny
EP2934540B1 (en) 2012-12-24 2023-08-02 Neurogastrx, Inc. Methods for treating gi tract disorders
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
MA41168A (fr) * 2014-12-17 2017-10-24 Acraf Nouveaux composés antibactériens
US12319659B2 (en) * 2017-02-24 2025-06-03 Shenzhen Linglan Bio-Pharmaceutical Technology Co., Ltd Selective ligand for dopamine D3 receptor, preparation method therefor, and pharmaceutical application thereof
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2836595A (en) * 1958-05-27 Piperazine derivatives and process for
US3138597A (en) * 1964-06-23 Phenylpiperazinylalkyl carbamates
CA683208A (en) * 1964-03-31 Hayao Shin Phenylpiperazinylalkyl esters and amides
GB952142A (en) * 1961-05-26 1964-03-11 Miles Lab Phenylpiperazinylalkyl carbamates
US4202898A (en) * 1978-06-05 1980-05-13 Synthelabo Method of treating anxiety and depression
AU532411B2 (en) * 1979-03-01 1983-09-29 Duphar International Research B.V. Phenyl piperazine derivatives
GB8303946D0 (en) * 1983-02-12 1983-03-16 Recordati Chem Pharm Antihypertensive n-piperazinylalkanoylanilides
US4882432A (en) * 1989-01-09 1989-11-21 American Home Products Corporation Polycyclic-carbamic acid piperazinoalkyl esters and amides
DK0402644T3 (da) * 1989-05-19 1996-01-02 Hoechst Roussel Pharma N-(Aryloxyalkyl)-heteroarylpiperidiner og -heteroarylpiperaziner, fremgangsmåde til deres fremstilli ng samt deres anvendelse som medikamenter
FR2655988B1 (fr) * 1989-12-20 1994-05-20 Adir Cie Nouveaux derives de la napht-1-yl piperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
DK0544765T3 (da) 1995-12-27
NO930631D0 (no) 1993-02-23
NZ239502A (en) 1994-07-26
EP0544765A1 (en) 1993-06-09
DE69111815T2 (de) 1996-04-18
IL99211A (en) 1996-01-31
JPH06500546A (ja) 1994-01-20
AU8441391A (en) 1992-03-17
PT98768B (pt) 1999-01-29
IL99211A0 (en) 1992-07-15
FI930799A0 (fi) 1993-02-23
EP0544765B1 (en) 1995-08-02
FI930799A7 (fi) 1993-02-23
AU653956B2 (en) 1994-10-20
DK203990D0 (da) 1990-08-24
WO1992003426A1 (en) 1992-03-05
NO930631L (no) 1993-04-23
IE912983A1 (en) 1992-02-26
PT98768A (pt) 1992-07-31
ZA916652B (en) 1992-05-27
US5246935A (en) 1993-09-21
DE69111815D1 (de) 1995-09-07
IE73475B1 (en) 1997-06-04
CA2089768A1 (en) 1992-02-25
ATE125802T1 (de) 1995-08-15

Similar Documents

Publication Publication Date Title
FI930262L (fi) Kinuklidinderivat
DE69119329D1 (de) Actinonin-Derivate
DE69125099D1 (de) Indolderivate
FI925523A0 (fi) Hydroxi- och alkoxipyridinderivat
FI942252L (fi) Piperatsiinijohdannaisia
FI914163A7 (fi) Heterosykliset johdannaiset
FI913045A7 (fi) Heterosykleenijohdannaisia
FI922481A7 (fi) Heterosyklisiä johdannaisia
FI930799L (fi) Piperazinylderivat
DE69208877D1 (de) Chinuclidinderivate
FI915507A7 (fi) Aryylijohdannaisia
DK247789D0 (da) Piperazinderivater
FI930878L (fi) A-substituerade tryptofan-dipeptoidderivat
NO922853D0 (no) Aminosubstituerte piperazinderivater
FI922347A7 (fi) Atsaoksindolijohdannaiset
ATE144765T1 (de) Hiv-hemmende benzenacetamidderivate
DE69130255D1 (de) Oxadolderivate
FI930109L (fi) 4-alkyl-imidazolderivat
LV11176A (lv) Uracila atvasinajumi
DK0472733T3 (da) Phenantrenderivater
FI932687A0 (fi) Antiallergiska foereningar
TR26336A (tr) SüBSTITüE EDILMIS PIRAZOLIN TüREVLERI
FI912598A7 (fi) Diokso-tetrahydrokinoliinijohdannaisia
FI912759A7 (fi) Pyridinyylipiperatsiinijohdannaisia
FI911925A7 (fi) Amiinijohdannaisia

Legal Events

Date Code Title Description
FD Application lapsed